<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Regulatory risk on FinanClub</title>
    <link>https://finan.club/tags/regulatory-risk/</link>
    <description>Recent content in Regulatory risk on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 18 Mar 2024 09:03:58 +0000</lastBuildDate><atom:link href="https://finan.club/tags/regulatory-risk/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>META</title>
      <link>https://finan.club/us/meta/</link>
      <pubDate>Mon, 18 Mar 2024 09:03:58 +0000</pubDate>
      
      <guid>https://finan.club/us/meta/</guid>
      <description>score:-44
Chances: The company&amp;rsquo;s FoA segment, which includes Facebook, Instagram, Messenger, and WhatsApp, continues to drive significant user engagement and revenue generation. The potential in the RL segment, with its focus on augmented, virtual, and mixed reality, could provide long-term growth opportunities for the company.</description>
    </item>
    
    <item>
      <title>HOOD</title>
      <link>https://finan.club/us/hood/</link>
      <pubDate>Mon, 18 Mar 2024 09:03:32 +0000</pubDate>
      
      <guid>https://finan.club/us/hood/</guid>
      <description>score:55
Chances: Robinhood Markets, Inc. (HOOD) has seen a surge in trading volumes and assets under custody in February 2024. The company&amp;rsquo;s focus on cryptocurrency trading and the recent excitement in the crypto markets could lead to further growth and benefits for Robinhood.</description>
    </item>
    
    <item>
      <title>TGTX</title>
      <link>https://finan.club/us/tgtx/</link>
      <pubDate>Mon, 11 Mar 2024 09:03:54 +0000</pubDate>
      
      <guid>https://finan.club/us/tgtx/</guid>
      <description>score:113
Chances: TG Therapeutics, Inc. has announced the presentation of data from the ULTIMATE I &amp;amp; II Phase 3 trials evaluating BRIUMVIÂ® in patients with relapsing forms of multiple sclerosis, indicating potential positive outcomes from the trials. The company has reported strong financial results, with BRIUMVI U.</description>
    </item>
    
    <item>
      <title>GOTU</title>
      <link>https://finan.club/us/gotu/</link>
      <pubDate>Wed, 28 Feb 2024 09:05:45 +0000</pubDate>
      
      <guid>https://finan.club/us/gotu/</guid>
      <description>score:51
Chances: Gaotu Techedu Inc. continues to demonstrate strong financial performance, with impressive unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Risks: The company operates in a highly competitive market, with potential risks from regulatory changes and shifts in consumer behavior.</description>
    </item>
    
  </channel>
</rss>
